Enhancement of antiproliferative activity of 1α,25-dihydroxyvitamin D3 (analogs) by cytochrome P450 enzyme inhibitors is compound- and cell-type specific
Authors:
- B.K. TanBTB.K. Tan
- S. MarcelisSMS. Marcelis
- A. VerstuyfAVA. Verstuyf
- R. BouillonRBR. Bouillon
- 1 February 1996
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 57 (3-4) , 197-202
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Functional Interference Between AP‐1 and the Vitamin D Receptor on Osteocalcin Gene Expression in Human Osteosarcoma CellsEuropean Journal of Biochemistry, 1994
- Sensitive and specific detection of retinoid receptor subtype proteins in cultured cell and tumor extractsMolecular Endocrinology, 1994
- Identification of a vitamin D responsive element in the promoter of the rat cytochrome P45024geneNucleic Acids Research, 1994
- Sex steroids induced up-regulation of 1,25-(OH)2 vitamin D3 receptors in T 47D breast cancer cellsThe Journal of Steroid Biochemistry and Molecular Biology, 1993
- Two nuclear signalling pathways for vitamin DNature, 1993
- Vitamin D3 binding activity during leukemic cell differentiationLeukemia Research, 1993
- CLINICAL COUNTERPOINT: Vitamin D: New Actions, New Analogs, New Therapeutic Potential*Endocrine Reviews, 1992
- Binding and metabolism of 1,25-dihydroxyvitamin D3 in cultured bovine parathyroid cellsEndocrinology, 1992
- Action of imidazole-containing antifungal drugsLife Sciences, 1981
- 1,25-dihydroxyvitamin D3 receptor in a cultured human breast cancer cell line (MCF 7 cells)Biochemical and Biophysical Research Communications, 1980